Introduction
Friend virus-induced erythroleukemia is a model for the multi-stage nature of cancer (Ben-David and Bernstein, 1991) . The initial stage of the disease is characterized by a polyclonal expansion of infected erythroid precursor cells. In the later stages, fully transformed clones emerge that contain additional genetic mutations, leading to the development of erythroleukemia (Moreau-Gachelin et al., 1988; Mowat et al., 1985) . Two variant strains of Friend virus exist: the polycythemia-inducing FVP and the anemia-inducing FVA. The virus is a complex of the replication defective spleen focus forming virus (SFFV) and the replication competent helper virus Friend murine leukemia virus (F-MuLV). The env gene of SFFV encodes a 55 kD glycoprotein (gp55) which is responsible for the virus-induced disease. Studies have shown that gp55 interacts with the 66 kD erythropoietin receptor (EpoR) (D'Andrea, 1992; Li et al., 1990) . Furthermore, co-expression of EpoR and gp55 in IL-3-dependent BaF/ 3 cells leads to factor-independent cell growth (Li et al., 1990) . Thus, gp55 appears to activate the EpoR and/or its downstream signaling pathways resulting in the expansion of infected erythroid progenitor cells.
Because of the characteristic progression of Friend erythroleukemia and the speci®city of Friend virus for the erythroid lineage, a number of genes have been identi®ed that control susceptibility to Friend erythroleukemia (Hoatlin and Kabat, 1995) . Some of these genes directly aect the ability of Friend virus to infect cells (Fv1 and Fv4). A second group of genes (W, Sl, f, and Fv2) are required for regulating the expansion of infected cells in the primary phase of Friend erythroleukemia (Ben-David and Bernstein, 1991) . Some of these genes, including W and Sl, which encode the c-kit receptor tyrosine kinase and its ligand stem cell factor (SCF), respectively, are also required for normal erythropoiesis. Recently, we demonstrated that Fv2 encodes the Stk/RON receptor tyrosine kinase (Persons et al., 1999) . Mice homozygous for the resistant allele of Fv2 (Fv2 rr ) fail to express a naturally occurring, Nterminally truncated form of the receptor, called short form-Stk (Sf-Stk). While expression of full-length Stk is unaected in these animals, the transcript encoding SfStk is derived from an internal promoter that is mutated in Fv2 rr mice. Sf-Stk lacks the majority of the extracellular domain of Stk, including the ligand binding domain, but retains the transmembrane and tyrosine kinase domains (Iwama et al., 1994) . Through the use of Stk-de®cient mice (Correll et al., 1997) , we demonstrated that Stk is required for Friend virus-induced expansion of erythroid progenitor cells (Persons et al., 1999) . Furthermore, enforced expression of Sf-Stk in transgenic mice is sucient to confer Friend virus susceptibility on Fv2 rr C57BL/6 mice (Persons et al., 1999) .
Stem cell-derived tyrosine kinase receptor (Stk) (Iwama et al., 1994 ) is a member of a family of receptor tyrosine kinases that includes mouse and human MET, human RON, and chicken SEA. It has been postulated that Stk, RON, and SEA are speciesspeci®c homologues of the same protein. The Stk receptor is composed of an extracellular a chain linked to a transmembrane b chain via disul®de bonds. The ligand for Stk, macrophage stimulating protein (MSP), is a serum protein that is activated by members of the coagulation cascade and is homologous to the MET ligand, hepatocyte growth factor (HGF). MSP acts upon a variety of cell types including macrophages, megakaryocytes, osteoclasts, and epithelial cells to induce a wide range of cellular eects such as proliferation, dierentiation, chemotaxis, phagocytosis, morphological changes, and alterations in nitric oxide production (Leonard, 1997; Liu et al., 1999) . MSP activation of the Stk/RON receptor results in upregulation of kinase activity and phosphorylation of a two tyrosine docking site in the C-terminal tail which is required for generating downstream signals. Point mutations in the kinase domain of the human RON and MET genes that lead to constitutive activity result in cellular transformation and enhanced tumorigenesis in nude mice (Jeers et al., 1997; Santoro et al., 1998) .
The initial phase of Friend disease is driven by a productive interaction between the viral protein gp55 and the host EpoR and the prevailing model suggests that this interaction leads to constitutive activation of the EpoR resulting in uncontrolled erythroid proliferation. However, recent studies have failed to demonstrate a requirement for tyrosines in the EpoR in the expansion of infected cells (Nishigaki et al., 2000) , and the EpoR associated kinase, Jak2, was not constitutively phosphorylated in these cells (Nishigaki et al., 2000; Yamamura et al., 1998) . Furthermore, the discovery that Sf-Stk is required for susceptibility to Friend disease adds a new level of complexity to the proposed mechanism. Recent studies by Nishigaki et al. (2001) have demonstrated that Sf-Stk forms disul®de-linked complexes with gp55 in hematopoietic cells expressing the EpoR, resulting in constitutive tyrosine phosphorylation of Sf-Stk. Therefore, we set out to determine whether signaling through Sf-Stk is required for gp55-mediated proliferation. Towards that end, we adapted an in vitro assay that allowed us to identify the essential subdomains of Sf-Stk. Here we show that SfStk kinase activity and the Grb2 binding site are required for gp55-mediated proliferation of infected erythroblasts, suggesting that Sf-Stk provides signals that drive Epo-independent growth of these cells.
Results

Sf-Stk expression confers Friend virus sensitivity in vitro
To examine the role of Sf-Stk in gp55-mediated proliferation, we adapted an in vitro Friend virus infection assay. In this assay, Sf-Stk expression is provided by retroviral infection of primary bone marrow cells from Fv2 rr mice. Following in vitro infection with the polycythemia-inducing strain of Friend virus (FVP), these cells were plated in a minimal methylcellulose media supplemented with interleukin-3 (IL-3) and then assessed for their ability to form Epo-independent erythroid colonies (CFU-E) and bursts (BFU-E). As shown previously, bone marrow cells from Fv2 ss BALB/c mice, but not Fv2 rr C57BL/6 mice, incubated with Friend virus are able to form Epo-independent CFU-E and BFU-E (Figure  1a ,b; (Bondurant et al., 1985; Clarke et al., 1975) ). Bone marrow cells from Fv2 rr C57BL/6 mice were then incubated with viral particles expressing vector alone or a myc-tagged Sf-Stk. Subsequently, the cells were washed, incubated with or without Friend virus, and assessed for erythroid colony formation in the presence or absence of Epo. As shown in Figure 1c ,d, Fv2 rr C57BL/6 bone marrow cells infected with the myc/SfStk retrovirus, followed by Friend virus infection, formed Epo-independent CFU-E and BFU-E, whereas those infected with the control retrovirus did not. In contrast, C57BL/6 bone marrow cells infected with either retrovirus formed CFU-E and BFU-E when cultured with Epo and IL-3. These data reveal that enforced expression of Sf-Stk confers Friend virus sensitivity in vitro to bone marrow cells from Fv2 rr mice.
Sf-Stk kinase activity is required for Friend virus sensitivity
To determine the role of Sf-Stk kinase activity in gp55-mediated erythroblast proliferation, we generated two or from C57BL/6 mice that were transduced with either vector alone or a Sf-Stk retrovirus (c, d) were infected in vitro with Friend virus (FVP). CFU-E colonies were counted after 2 days of culture, and BFU-E colonies were counted after 8 days of culture. Number of colonies on the y-axis represents number of colonies minus background (number of colonies with no treatment). Results represent the average of three independent experiments. *P50.05; **P50.005 distinct kinase-inactive forms of Sf-Stk. First, we mutated two adjacent conserved tyrosine residues in the activation loop of the kinase domain to phenylalanine (Y314/315F) (Figure 2a ). The homologous tyrosines in MET are required for autophosphorylation of the receptor and phosphorylation of exogenous substrates . In addition, mutation of these tyrosines abrogates the transforming capabilities of the met oncogene (Zhen et al., 1994) . As shown in Figure 3a , mutation of these residues in Sf-Stk results in a dramatic decrease in kinase activity compared to that of wild-type Sf-Stk.
In most receptor tyrosine kinases (including MET, RON, and SEA) an aspartic acid is highly conserved in the activation loop of the catalytic domain (Figure 2a ). In contrast, non-receptor tyrosine kinases, such as Src and Abl, are not homologous to receptor tyrosine kinases at this catalytic domain residue despite considerable homology throughout the rest of the kinase domain. In several receptor tyrosine kinases, mutation of the conserved aspartic acid leads to constitutive activation and altered substrate speci®city (Jeers et al., 1997; Piao et al., 1996; Santoro et al., 1998) . The murine Stk gene has a glycine at position 308 instead of the conserved aspartic acid (Iwama et al., 1994) . When Stk was sequenced from several dierent strains of mice (C57BL6/J, BALB/cJ, DBA2 and C3HeJ), we found that glycine is present in all strains tested (data not shown). In the KIT receptor, introduction of a glycine for the conserved aspartic acid results in a mildly activated receptor (Moriyama et al., 1996) . Sf-Stk may therefore represent an activated form of the receptor. To examine the eect of this amino acid dierence on Sf-Stk kinase activity, we mutated the glycine at position 308 back to the conserved aspartic acid (G308D) (Figure 2a) . Interestingly, this mutation resulted in decreased kinase (Figure 3a) , suggesting that the presence of a glycine at position 308 may contribute to a higher basal level of kinase activity.
To determine the role of Sf-Stk kinase activity in gp55-mediated erythroblast proliferation, we examined these Sf-Stk kinase domain mutants for their ability to support Epo-independent colony formation in our in vitro assay. As shown in Figure 3b , neither kinase domain mutant was able to confer sensitivity to Friend virus following expression in bone marrow cells from Fv2 rr mice, while wild-type Sf-Stk expression resulted in Epo-independent colony formation. Expression of vector alone, Sf-Stk, or either kinase domain mutant had no eect on the ability of Epo to induce CFU-E formation, indicating that expression of the mutants had no eect on normal EpoR signaling. Figure 3c demonstrates that equivalent amounts of protein were expressed from each construct in the transfected packaging cell line. These results demonstrate that SfStk kinase activity is required for Epo-independent expansion of erythroid progenitors in response to Friend virus. Furthermore, the presence of a glycine at position 308 in murine Stk is required for its ability to cooperate with Friend virus in the induction of Epoindependent colonies.
Docking site tyrosine 436 and the consensus Grb2 binding site of Sf-Stk are required for gp55-mediated erythroblast expansion
In order to determine whether activation of signaling pathways downstream of Sf-Stk is required for its ability to promote Epo-independent growth in response to Friend virus infection, we constructed mutations in the multifunctional docking site of the Sf-Stk cytoplasmic domain (Figure 2a ). Upon phosphorylation, the two tyrosines of this site in the Stk/RON, MET, and SEA receptors can serve as binding sites for SH2 domain-containing signaling proteins such as Grb2, Gab1, phosphatidylinositol 3-kinase (PI 3-kinase), Shc, PLCg1, SHP-2, and SHIP-1 (Iwama et al., 1996; Nguyen et al., 1997; Park and Hayman, 1999; Stefan et al., 2001) . Two mutant constructs were created by substituting phenylalanine for each of these tyrosines (Y429F and Y436F), and these constructs were tested in the in vitro assay. Figure 4a reveals that mutation at Y436, but not Y429, eliminated Epo-independent CFU-E formation in response to Friend virus. Expression of the docking site mutants had no eect on the ability of Epo to support CFU-E formation. Equivalent amounts of protein were expressed from each construct in transfected packaging cells ( Figure  4b ).
These data reveal that mutation of the C-terminal docking site tyrosine eliminated Epo-independent CFU-E in response to Friend virus infection. Since this docking site tyrosine can interact with multiple signaling partners, we mutated an alternative residue of this docking site in order to dissect which signaling proteins downstream of Sf-Stk are important for Epoindependent growth of Friend virus-infected cells. Based on consensus SH2 domain binding sites (Songyang et al., 1994) , we mutated the asparagine residue at position +2 relative to tyrosine 436 to a histidine to abrogate binding of Grb2 to the docking site (Figure 2a ). In the MET receptor, this mutation eliminates Grb2 binding while interactions with other SH2 domain-containing proteins are maintained . Using a Grb2 SH2 GST fusion protein, we demonstrate that the N438H mutation inhibits binding of Grb2 to the Sf-Stk receptor ( Figure  5a ). When tested in the in vitro assay, the N438H mutant was unable to confer Friend virus sensitivity, while Epo-stimulated colonies were unaected by this mutation (Figure 5b ). To determine whether Grb2 binding is sucient, we mutated Y 436 VNV to YHNQ, the Grb2 binding site from the EGFR (Figure 2a ). This construct resulted in the binding of Grb2 (Figure 5a ) and rescued the growth of C57BL/6 erythroblasts in response to Friend virus in vitro (Figure 5b ). Figure 5c demonstrates equivalent Myc/Sf-Stk expression in the packaging cells from these constructs. Taken together, the results obtained with these docking site mutants suggest that a Grb2-dependent pathway downstream of Sf-Stk is required to promote expansion of erythroid progenitor cells in response to Friend virus.
The ERK MAPK and PI3K pathways are activated downstream of Sf-Stk
Grb2 can function to link receptor tyrosine kinases to the Ras/MAPK pathway via interaction with the guanine exchange factor Sos. To determine if this pathway is activated downstream of Sf-Stk, we analysed lysates from NIH3T3 cells expressing vector alone or myc-tagged Sf-Stk. We observed enhanced levels of phosphorylated ERK protein in lysates from the Sf-Stk-expressing cells (Figure 6a ), but not from cells expressing the kinase domain mutants (Figure 6b ), suggesting that ERK is activated by the Sf-Stk receptor in a kinase-dependent manner. The functional relevance of ERK activation in Friend erythroleukemia was subsequently assessed by addition of the MEK inhibitor PD98059 to the in vitro colony assay system. Figure 6d reveals that addition of the inhibitor blocked Friend virus-induced, Epo-independent colonies from Sf-Stk-transduced Fv2 rr bone marrow cells. In addition, as demonstrated previously, the inhibitor was eective at abrogating Epo-stimulated CFU-E in these cells.
The c-terminal SH3 domain of Grb2 has also been shown to bind to a polyproline-rich region in the large adaptor protein, Gab1, resulting in the recruitment of Gab1 to receptor complexes. Gab1, in turn, contains at Lysates from NIH3T3 cells expressing vector alone, myc/Sf-Stk, myc/Sf-Stk, Y314/315F myc/Sf-Stk, or G308D myc/Sf-Stk were separated by SDS ± PAGE, transferred to PVDF, and probed with antiphospho-ERK. The blot was stripped and reprobed with antimyc. (c) Lysates from NIH3T3 cells expressing vector alone or myc/Sf-Stk were immunoprecipitated with anti-Akt, and an in vitro kinase assay was performed using GSK3 as a substrate. The same lysates were separated by SDS ± PAGE, transferred to PVDF and probed with anti-myc. (d) Bone marrow cells from C57BL/6 mice were transduced with myc/Sf-Stk and were infected in vitro with Friend virus (FVP). One mM PD98059, 100 nM Wortmannin or DMSO was added to the methocult media along with the transduced cells. (e) Bone marrow cells from C57BL/6 mice were transduced with myc/Sf-Stk with or without coexpression of a dominant negative p85 and infected in vitro with FVP. Colonies were counted 2 days later to assess numbers of CFU-E. Number of colonies on the y-axis represents number of colonies minus background. Results represent the average of three and four independent experiments in panel d and e, respectively. *P50.02 least three p85 binding sites for the activation of PI3K. p85 has also been shown to bind directly to the YVNV sequence in Met and Ron. Figure 6c demonstrates increased activation of Akt, a downstream eector of PI3K, in NIH3T3 cells expressing Sf-Stk. In order to determine whether PI3K is required for the expansion of erythroblasts in response to Friend virus infection, we performed the in vitro assay in the presence of the PI3K inhibitor, wortmannin (Figure 6d) . Results from these studies suggest that the activation of PI3K is required for gp55-mediated, but not Epo-induced, growth of primary erythroblasts. These results are con®rmed by the co-expression of Sf-Stk and a dominant negative p85 tagged with GFP in place of the neomycin resistance gene in the retroviral vector (Figure 2c) , which fails to rescue the response of transduced cells to Friend virus (Figure 6e ). Sf-Stk expression and DN p85 expression were con®rmed in the packaging cells by Western blot and green uorescence, respectively (data not shown). Taken together, these data suggest that ERK and PI3K activation downstream of Sf-Stk may be important for Epo-independent growth of Friend virus infected cells.
Discussion
There are several mechanisms by which the Sf-Stk receptor tyrosine kinase may contribute to Friend virus-induced erythroblastosis. Previous studies have shown that gp55 and EpoR physically interact to promote expansion of Friend virus-infected erythroblasts. Therefore, Sf-Stk may serve to coordinate or stabilize interactions between gp55 and EpoR. Alternatively, Sf-Stk may actively participate in the downstream signaling events involved in gp55-mediated proliferation. In this paper, we utilized an in vitro infection assay to map the cytoplasmic domain features of Sf-Stk required for gp55-mediated proliferation in primary erythroid cells. We found that Sf-Stk kinase activity and tyrosine docking sites are essential for gp55-mediated proliferation.
Previous work has shown that Friend virus infection results in Epo-independent activation of STAT proteins (Ohashi et al., 1995; Yamamura et al., 1998) as well as Epo-independent tyrosine phosphorylation of Gab1 and Gab2 (Nishigaki et al., 2000) . Studies of the Stk family member MET reveal that receptor engagement leads to tyrosine phosphorylation of STAT3 (Boccaccio et al., 1998) and Gab1 (Nguyen et al., 1997) . Sf-Stk kinase activity may target the EpoR and/ or Jak1 since constitutive tyrosine phosphorylation of both of these proteins is observed in Friend virusinfected primary splenic erythroblastoid cells (Yamamura et al., 1998) . However, the signi®cance of EpoR tyrosine phosphorylation is unclear since studies with a mutant EpoR construct demonstrate that EpoR tyrosine phosphorylation is not required for Epoindependent proliferation of Friend virus-infected cells (Nishigaki et al., 2000) . With the exception of Jak1, no other Jak family kinase has been shown to be constitutively active in Friend virus-infected cells (Nishigaki et al., 2000; Yamamura et al., 1998) . Thus, there may be another kinase involved in Friend virusinduced tyrosine phosphorylation, and our data suggest that Sf-Stk is a likely candidate kinase that initiates these phosphorylation events.
Comparison of the sequence of the murine Stk kinase domain with that of the related proteins, human RON and chicken SEA, revealed that the Stk gene has a glycine residue instead of aspartic acid at position 308 in the kinase domain (relative to the amino terminus of Sf-Stk). Mutation of this aspartic acid residue has been observed in the KIT and MET receptor tyrosine kinases and is associated with human disease (Longley et al., 1996; Schmidt et al., 1997) . We found that substitution of aspartic acid for glycine at position 308 in Sf-Stk reduced the kinase activity of SfStk and blocked the ability of Sf-Stk to rescue Epoindependent colony formation. These results correlate well with studies in the KIT receptor demonstrating that substitution of glycine for aspartic acid at position 816 resulted in a mildly activated receptor (Moriyama et al., 1996) . Since the glycine at position 308 diverges from the conserved aspartic acid residue found in most receptor tyrosine kinases, we sequenced the Stk kinase domain from multiple mouse strains and observed a glycine at this position in each instance, ruling out the possibility that a mutation was introduced during the cloning of Stk or that this glycine represents a polymorphism in the murine Stk locus. Interestingly, expression of Stk has recently been shown to be transforming in NIH3T3 cells (Peace et al., 2001) , whereas expression of human RON, which has the conserved aspartic acid at this position, fails to transform these cells (Santoro et al., 1998) . Thus, the presence of a glycine residue at position 308 appears to be murine-speci®c, and may be exploited by Friend virus to aid in the expansion of infected cells.
In addition to potential phosphorylation of eector proteins, autophosphorylation of the docking site tyrosines in the C-terminal tail of Sf-Stk may play a role in recruiting downstream signaling molecules required for Epo-independent proliferation of Friend virus-infected cells. In the Stk receptor, the more Cterminal docking site tyrosine has been shown to recruit Grb2, PI 3-kinase, Shc, and PLCg1 (Iwama et al., 1996) , while the more membrane proximal tyrosine in the MET receptor serves as a binding site for the Gab1 adaptor protein (Nguyen et al., 1997) . In vivo, mutation of both MET docking site tyrosines resulted in embryonal death, with placenta, muscle, and liver defects similar to those in MET de®cient mice (Maina et al., 1996) . However, mutation of the consensus Grb2 binding site alone allowed development to proceed to term with an accompanying defect in muscle development, suggesting that, in vivo, the roles of the two tyrosine-based docking sites can be uncoupled. Mutational analyses have revealed that an intact docking site is required for the transforming capabilities of the v-sea and Tpr-met oncogenes. In Rat1 cells expressing v-sea, mutation of both docking site tyrosines, but not either one alone, blocked transformation (Park and Hayman, 1999) . Studies with Tpr-Met demonstrate that the Grb2 binding site in particular is required for transformation (Fixman et al., 1996) , which is consistent with our results demonstrating that the analogous site in Sf-Stk is required for Friend virusinduced transformation. Thus, the studies described in this paper support the idea that receptor autophosphorylation of the multifunctional docking site is critical for the expansion of infected erythroblasts.
The central role of Grb2 downstream of Sf-Stk suggests that Grb2-dependent signaling pathways play a vital role in the proliferation of Friend virus infected erythroid progenitors. Grb2 is known to link receptors to the Ras-dependent activation of ERK (Gong et al., 2001) . We demonstrate that Sf-Stk can activate ERK in NIH3T3 cells, and our lab has also observed that MSP stimulation of the Stk receptor leads to increased ERK phosphorylation in expanded primary erythroblast cells (Teal HE and Correll PH, unpublished observations) . Furthermore, we show that the MEK inhibitor PD98059 blocks the formation of Epoindependent CFU-E by Friend virus. This situation may be similar to the synergistic activation of MAPK by Epo and SCF that is associated with the expansion of erythroid progenitors.
In addition to Ras signaling pathways, Grb2 may also link Sf-Stk to other adapter proteins. Sf-Stk harboring a mutation at Y429, the putative Gab1 binding site, was fully capable of rescuing Friend virus sensitivity in our assay system. However, these studies do not rule out a role for Gab1 in Friend virus-induced transformation, as Gab1 could be recruited to the receptor via interaction with Grb2. Tyrosine phosphorylated Gab1, as well as Gab2 and IRS-2, have been shown to be constitutively associated with PI 3-kinase activity in Friend virus-infected cells (Nishigaki et al., 2000) , suggesting that these adapter molecules may play a role in Friend virus-induced Epoindependent signaling pathways. Our data demonstrate activation of PI3K in cells expressing Sf-Stk and a requirement for this pathway in the expansion of Friend virus-infected cells. Moreover, while our results demonstrate a requirement for Grb2 binding to the receptor, they do not exclude the possibility that other SH2 domain-containing proteins that bind to Y436, including p85, may also contribute to gp55-mediated expansion of erythroid progenitors.
Sf-Stk is closely related to the avian erythroblastosis virus S13-encoded oncogene v-sea (Hu et al., 1993) . This oncogene encodes a 155 kD transmembrane glycoprotein composed of extracellular and transmembrane sequences from the viral env gene and the intracellular domain of the c-sea receptor tyrosine kinase (Smith et al., 1989) . The envelope sequences of v-sea are thought to lead to constitutive dimerization of the receptor, and studies have demonstrated that the oncoprotein is constitutively autophosphorylated (Park and Hayman, 1999) . Furthermore, the S13 virus causes sarcomas, erythroblastosis, and anemias after injection into chicks, and v-sea is capable of transforming chicken erythroid cultures in vitro (Smith et al., 1989) . Thus, the v-sea oncogene exerts activities that are strikingly similar to those hypothesized to be exerted via Sf-Stk, gp55, and the EpoR. One possibility, suggested by the structure of v-sea, is that gp55 and Sf-Stk interact to form the functional equivalent of v-sea. In support of this theory, Nishigaki et al. (2000) have shown that Sf-Stk and gp55 interact in cells expressing EpoR, resulting in constitutive activation of Sf-Stk. Furthermore, we have observed that Sf-Stk co-immunoprecipitates with gp55 and the EpoR in transfected COS-1 cells (P Ney, unpublished observations).
For several years, the prevailing hypothesis regarding the mechanism by which Friend virus induces erythroblast expansion has invoked the idea that constitutive activation of EpoR-mediated signaling, via interaction of the EpoR with the gp55 envelope glycoprotein, leads to disease. However, in light of the fact that several genes have been identi®ed that control susceptibility to Friend erythroleukemia, it is clear that host factors other than EpoR regulate progression of the disease. It has been widely speculated that these factors may promote or inhibit the interaction between EpoR and gp55. Our recent discovery that the susceptibility gene, Fv2, encodes a receptor tyrosine kinase is intriguing since Stk could provide more than just a physical link between the viral protein and EpoR. While Sf-Stk could play a role in stabilizing the interaction between gp55 and EpoR, the studies presented in this paper clearly demonstrate that signaling through Sf-Stk is a critical component of Friend virus-induced erythroblast expansion. It is also quite possible that additional components may be involved in this signaling complex and/or additional signals may be required to promote erythroleukemogenesis. Thus, in a larger context, investigation of Friend virus-induced erythroleukemia will advance our understanding of ways in which cytokine receptors and receptor tyrosine kinases might interact directly and/or via integrated eectors to regulate normal versus leukemic growth and dierentiation programs.
Materials and methods
DNA constructs
The Sf-Stk cDNA was cloned into the pcDNA3-Myc6 vector (kindly provided by D Wojchowski, Pennsylvania State University, University Park, PA, USA) using EcoRI and XhoI and subsequently the 1.8 kb myc-tagged Sf-Stk was ligated into the BamHI and ApaI sites of the pSL1180 shuttling vector (provided by D Wojchowski). Finally, the tagged Sf-Stk was excised from pSL1180-Myc/Sf-Stk with BamHI and BglII and cloned into the BglII site of the MSCV-neo retroviral vector (kind gift of A Henderson, Pennsylvania State University, University Park, PA, USA) to produce MSCV-neo-Myc/Sf-Stk.
The Quick Change Mutagenesis Kit (Stratagene, La Jolla, CA, USA) was used to mutate the Sf-Stk kinase domain in the pSL11080-Myc/Sf-Stk construct using the following mutagenic oligonucleotides: for Y314/315F 5'-GCGTCCTA-GACAAGGAATTCTTCAGTGTTCGCCAGCATC-3' and 5'-GATGCTGGCGAACACTGAAGAATTCCTTGTCTA-GGACGC-3'; for G308D 5'-CTTTGGTCTGGCACGG-GACGTCCTAGACAAGGAATAC-3' and 5'-GTATTCCT-TGTCTAGGACGTCCCGTGCCAGACCAAAG-3'; for N438H 5'-GCTGACAGCAGCTTATGTGCACGTAGGC-CCCAGAGCG-3' and 5'-CGCTCTGGGGCCTACGTGCA-CATAAGCTGCTGTCAGC-3'; for V437H/V439Q 5'-GTG-CAGCTGACAGCAGCTTATCACAACCAAGGCCCCAG-AGCGGTGG-3' and 5'-CCACCGCTCTGGGGCCTTGGT-TGTGATAAGCTGCTGTCAGCTGCAC-3'. The mutant myc-tagged Sf-Stk DNA was cloned into MSCV-neo as described above to produce MSCV-neo-Myc/Sf-StkY314/ 315F, MSCV-neo-Myc/Sf-StkG308D, MSCV-neo-Myc/SfStkN438H and MSCV-neo-Myc/Sf-StkV437H/V439Q.
Stk sequences encoding docking site tyrosine mutations Y429F and Y436F were excised from pMKIT-Stk vectors (kind gift of T Suda, Kumamoto University School of Medicine, Kumamoto, Japan) with SmaI and NotI, the NotI site was ®lled in, and then the fragment was cloned into SmaI digested pSL1180-Myc/Sf-Stk. Finally, the 1.5 kb EcoRI fragment encoding the mutated Sf-Stk was cloned into EcoRI digested MSCV-neo-Myc/SF-Stk vector to produce MSCVneo-Myc/Sf-StkY429F and MSCV-neo-Myc/Sf-StkY436F.
Transient transfections
The 293T cell line was acquired from A Henderson (Pennsylvania State University, University Park, PA, USA) and grown in DMEM containing 10% FCS, penicillin/ streptomycin, and L-glutamine. Cells were transiently transfected by CaPO 4 coprecipitation using 5 mg each of pEco (provided by A Henderson) and the appropriate MSCV-neo vector and incubated for 16 h at 378C. Media was aspirated, fresh media was added, and cells were grown for 8 h at 378C prior to harvest of viral supernatant.
To assess protein expression levels, transfected 293T cells were lysed with TPER lysis reagent (Pierce, Rockford, IL, USA) containing 1 mM PMSF and 10 mg/ml aprotinin. Lysates were cleared by centrifugation at 12 000 r.p.m. for 20 min at 48C. Equivalent amounts of protein were separated by SDS ± PAGE on a 7.5% gel and transferred to PVDF membrane (Millipore, Bedford, MA, USA). The membrane was blocked overnight in blocking buer (TBS/0.05% Tween/ 5% milk) and then immunoblotted with anti-myc monoclonal antibody (Invitrogen, Carlsbad, CA, USA; 1 : 5000 in blocking buer) and goat anti-mouse HRP (Sigma, St. Louis, MO, USA; 1 : 2000 in blocking buer) and protein bands were detected by enhanced chemiluminescence (Pierce).
In vitro infection and colony assays
Bone marrow cells were harvested from femurs and tibias of 48-week-old BALB/c or C57BL/6 mice, washed 16 in DMEM, and resuspended at 2610 6 cells/ml in DMEM containing 20% FCS, 16penicillin/streptomycin, 16L-glutamine, 0.1 mM b-mercaptoethanol, and 16nonessential amino acids. One milliliter viral supernatant from transiently transfected 293T cells was added to 4 ml of bone marrow cells along with 8 mg/ml hexadimethrine bromide (Sigma, St. Louis, MO, USA) and incubated for 16 ± 18 h at 378C. Cells were centrifuged at 1500 r.p.m. for 5 min, washed 26 with sterile PBS, resuspended in DMEM or supernatant from cells expressing the polycythemia-inducing Friend virus strain (FVP) (derived from FP63 cells kindly provided by A Bernstein, Mount Sinai Hospital, Toronto, Ontario, Canada), and incubated on ice for 1 h. Cells were added to methocult media M3234 (Stem Cell Technologies, Vancouver, BC, USA) along with 2.5 ng/ml IL-3 (Peprotech, Rocky Hill, NJ, USA) with or without 1 U/ml Epo (R&D Systems, Minneapolis, MN, USA) and dispensed into tissue culture plates. For experiments using the MEK inhibitor PD98059 (New England BioLabs, Beverly, MA, USA) or the PI3K inhibitor Wortmannin (Sigma Chemical Company), a ®nal concentration of 1 mM or 100 nM inhibitor, respectively, or equivalent amount of DMSO was also added to the methocult media. After 2 (CFU-E) or 8 (BFU-E) days of incubation at 378C, samples were treated with benzidine stain (1 ml 3.3% benzidine base (0.33 g benzidine, 9 ml acetic acid, 1 ml water), 5 ml water, 1 ml H 2 O 2 ) and blue colonies were counted.
In vitro kinase assay 293T cells were transiently transfected with MSCV-neo, MSCV-neo-Myc/SF-Stk, MSCV-neo-Myc/SF-StkY314/315F, or MSCV-neo-Myc/SF-StkG308D and lysed with TPER lysis reagent containing 1 mM PMSF, 10 mg/ml aprotinin, and 1 mM sodium orthovanadate. Lysates were cleared by centrifugation at 12 000 r.p.m. for 20 min at 48C. Equivalent amounts of protein from each lysate were immunoprecipitated with anti-myc antibody at 48C, washed 36 with lysis buer, washed 26 with kinase buer (25 mM HEPES, pH 7.4, 5 mM MnCl 2 ), and incubated with 19.5 ml kinase buer and 0.5 ml g 32 P-ATP (10 mCi/ml) for 20 min at 258C. Samples were boiled for 5 min with 5 ml 46 sample buer (125 mM Tris-Cl, pH 6.8, 20% glycerol, 10% b-mercaptoethanol, 4.6% SDS, 0.01 mg/ml bromophenol blue), centrifuged for 1 min, and then separated by SDS ± PAGE and transferred to PVDF. The membrane was blocked overnight in blocking buer and then immunoblotted with anti-myc and goat anti-mouse HRP as described above, and protein bands were detected by enhanced chemiluminescence. After immunoblotting, the membrane was incubated in 1 M KOH for 2 h at 558C and then exposed to ®lm overnight to detect autophosphorylated proteins. Activity was quanti®ed by scanning densitometry (Molecular Dynamics, Sunnyvale, CA, USA).
Grb2 SH2 interactions
Lysates from 293T cells transiently transfected with MSCVneo, MSCV-neo-Myc/SF-Stk, MSCV-neo-Myc/SF-StkN438H or MSCV-neo-Myc/Sf-StkV437H/V439Q were immunoprecipitated with anti-myc antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) and then subjected to an in vitro kinase assay as described above with cold 100 mM ATP in place of g 32 P-ATP. Samples were boiled 5 min, cooled on ice, and then 200 ml cold lysis buer was added. After centrifugation at 12 000 r.p.m. for 2 min, supernatant was transferred to 7 ml Grb2 SH2 GST agarose conjugate (Santa Cruz) and incubated 3 h at 48C rotating. Samples were washed 46with lysis buer, boiled 5 min with 16sample buer, separated by SDS ± PAGE, and transferred to PVDF. After blocking in TBST/5% milk, the membrane was immunoblotted with anti-myc mAb (1 : 1000 in blocking buer) followed by goat anti-mouse HRP (1 : 2000) and detection by ECL.
ERK and Akt activation
NIH3T3 cells were infected with supernatant from 293T cells co-transfected with MSCV-neo, MSCV-neo-Myc/SF-Stk, MSCV-neo-Myc/Sf-StkY314/315F or MSCV-neo-Myc/SfStkG308D and pEco as described above. Cells were then selected with 1 mg/ml G418 (Life Technologies, Rockville, MD, USA), individual clones were isolated and lysates were prepared from using NP40 lysis buer (10 mM Tris-Cl, pH.7.4, 150 mM NaCl, 1% NP40 with 1 mM PMSF, 10 mg/ ml aprotinin, and 1 mM sodium orthovanadate). For ERK activation, lysates were separated by SDS ± PAGE, transferred to PVDF, and the membrane was immunoblotted with anti-phospho ERK (New England BioLabs; 1 : 1000) and goat anti-rabbit HRP followed by ECL detection. The membrane was then stripped and re-probed with anti-ERK (New England BioLabs; 1 : 1000). Akt activity was determined using an Akt kinase assay kit (Cell Signaling Technology). Brie¯y, lysates were immunoprecipitated with an immobilized anti-Akt antibody followed by incubation with a GSK-3 fusion protein in the presence of ATP to allow in vitro phosphorylation of GSK-3 by activated Akt. Phosphorylated GSK-3 was measured by Western blotting using a phospho-GSK-3a/b antibody.
